Phase 3 Ampullary Cancer Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
Periampullary CancerPostoperative Pancreatic Fistula
Technische Universität Dresden32 enrolled1 locationNCT05843877
Recruiting
Phase 3
Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Pancreatic CancerCholangiocarcinomaPancreatic Ductal Adenocarcinoma+4 more
Minia University194 enrolled1 locationNCT07155525
Recruiting
Phase 3
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Pancreas CancerPancreas AdenocarcinomaPancreatic Cancer Resectable+3 more
Minia University262 enrolled1 locationNCT07081360
Active
Phase 3
Adjuvant Chemotherapies in Resectable Pancreatic Cancer
Histologically proven ductal or ampullary cancer of the pancreas having undergone 'curative' resection
Australasian Gastro-Intestinal Trials Group (AGITG)1,090 enrolled2 locationsACTRN12605000361606